Ascites clinical trials

Explore recruiting ascites clinical trials.

Recruiting ascites studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ascites trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomised Phase III Trial of First Line Intraperitoneal Paclitaxel and Systemic Therapy versus Systemic Therapy Alone in Gastric Cancer Patients with Peritoneal Metastases

Italy, Sweden, Netherlands, Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Open-Label, Long-Term Safety Extension Study Evaluating the Safety and Tolerability of the Fixed-Dose Combination of Obeticholic Acid and Bezafibrate in Subjects with Primary Biliary Cholangitis

Netherlands, France, Norway, Hungary, Italy, Lithuania +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Safety and efficacy of a human albumin solution with restored structural profile in patients with decompensated cirrhosis

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Compensated Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Spain, Hungary, Netherlands, Belgium, Bulgaria, Germany +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-label Phase 1/2 Multicentre Study to Evaluate the Safety, Tolerability and Efficacy of RTX001 Autologous Macrophages in Participants with Liver Cirrhosis who have Hepatic Decompensation (EMERALD)

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Encapsulated Fecal Microbiota Transfer to Treat Immune Activation in Patients with Cirrhosis and Ascites (TransImmune) – A randomized, double-blind, placebo-controlled phase IIa clinical pilot study

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Ascites trials by city

Ascites in Toronto Ascites in Vancouver Ascites in Montreal Ascites in Calgary Ascites in Edmonton Ascites in Ottawa Ascites in Winnipeg Ascites in Quebec City Ascites in Hamilton Ascites in Kitchener Ascites in London Ascites in Halifax Ascites in New York Ascites in Los Angeles Ascites in Chicago Ascites in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease